Nasal lavage

PROCEDURE8 trials

Sponsors

Imperial College London, Hamilton Health Sciences Corporation, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, National Institute of Allergy and Infectious Diseases (NIAID), Mitchell Grayson

Conditions

Allergic RhinitisAsthmaAsthma AttackCovid19EosinophilsHayfeverLung Diseases, ObstructiveNasal Allergy

Phase 1

Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00159341

Imperial College LondonLung Diseases, Obstructive

Start: 2005-09-30End: 2006-12-31Updated: 2023-09-14

The Anti-allergic Effects of Specific Probiotics

CompletedNCT00480129

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sAllergic Rhinitis

Start: 2007-05-31End: 2007-10-31Updated: 2021-08-27

Phase 2

Repeat Nasal Allergen Challenge

CompletedNCT00290368

Imperial College LondonHayfever

Start: 2006-02-28End: 2006-05-31Target: 22Updated: 2023-09-14

Unknown Phase

Nasal Lavage Study: Comparing Single Versus Multi Sample Lavages

CompletedNCT00229190

Hamilton Health Sciences CorporationEosinophils, Nasal Lavage Fluid, Reproducibility of Results

Start: 2004-09-30End: 2005-05-31Target: 21Updated: 2007-04-24

Human Rhinovirus Infection and Airway Remodeling Mediators

TerminatedNCT01847768

National Institute of Allergy and Infectious Diseases (NIAID)Asthma

Start: 2013-04-30End: 2015-07-31Updated: 2015-08-14

Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects

CompletedNCT03039101

Mitchell GraysonNasal Allergy

Start: 2017-09-06End: 2018-07-16Updated: 2019-10-07

Nasal Irrigation to Reduce COVID-19 Morbidity

CompletedNCT04559035

Augusta UniversityCovid19

Start: 2020-09-24End: 2021-11-04Updated: 2021-12-28

Asthma: Phenotyping Exacerbations 3

University of NottinghamAsthma Attack

Start: 2022-05-09End: 2023-12-31Target: 100Updated: 2022-07-06